| Literature DB >> 33316575 |
Christiaan R de Vries1, Qingquan Chen1, Sally Demirdjian1, Gernot Kaber1, Arya Khosravi1, Dan Liu1, Jonas D Van Belleghem1, Paul L Bollyky2.
Abstract
Bacteriophages have attracted extensive interest in vaccine design. This includes the use of phage display technology to select antigens, the use of engineered phages displaying target antigens in vaccine formulations, and phage DNA vaccines. However, the development of these approaches is limited in part by uncertainty regarding the underlying mechanisms by which phages elicit immunity. This has stymied the clinical development of this technology. Here we review the immunology of phage vaccines and highlight the gaps in our knowledge regarding the underlying mechanisms. First, we review the basic biology of phages and their use in vaccines. Next we discuss what is known about the mechanisms of immunity against engineered phages and phage DNA. Finally, we highlight the gaps in our understanding regarding the immunogenicity of these preparations. We argue that mechanistic insight into the immunology of phage vaccines is essential for the further development and clinical utility of these technologies.Entities:
Mesh：
Substances：
Year: 2020 PMID： 33316575 PMCID： PMC8137517 DOI： 10.1016/j.copbio.2020.11.002
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN： 0958-1669 Impact factor: 9.740